Original Research

Published on 31 Jul 2024

Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients

in Pharmacology of Infectious Diseases

Di Li
Qimei Fang
Zhiwei Chen
Jing Tang
Haoling Tang
Nan Cai
Ke Qiu
Mingyang Zhu
Xuemei Yang
Lu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381830

674 views

Original Research

Published on 29 Jul 2024

Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in Mycobacterium tuberculosis: A computational approach

in Pharmacology of Infectious Diseases

Mandeep Chouhan
Prashant Kumar Tiwari
Richa Mishra
Saurabh Gupta
Mukesh Kumar
Eman Abdullah Almuqri
Nasir A. Ibrahim
Nosiba Suliman Basher
Anis Ahmad Chaudhary
Vivek Dhar Dwivedi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403900

664 views

Original Research

Published on 23 Jul 2024

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury

in Pharmacology of Infectious Diseases

Quanxian Liu
Lu Huang
Hong Yan
Zhaojing Zong
Zhenyong Chen
Xiaoyan Wu
Ling Chen
Yuanbo Lan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1406454

358 views

Original Research

Published on 19 Jul 2024

Monoterpene antifungal activities: evaluating geraniol, citronellal, and linalool on Candida biofilm, host inflammatory responses, and structure–activity relationships

in Pharmacology of Infectious Diseases

Priscilla Guimarães Silva Vasconcelos
Kyu Min Lee
Gabriel Flores Abuna
Edja Maria Melo Brito Costa
Ramiro Mendonça Murata

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394053

544 views

Original Research

Published on 17 Jul 2024

Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate

in Pharmacology of Infectious Diseases

Wei Li
Yu Liu
Lu Xiao
Xuezhou Cai
Weixi Gao
Dong Xu
Shishi Han
Yan He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1409998

420 views

Review

Published on 15 Jul 2024

Advancing vaccine development against Opisthorchis viverrini: A synergistic integration of omics technologies and advanced computational tools

in Pharmacology of Infectious Diseases

Alok Kafle
Suvash Chandra Ojha

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410453

682 views

Original Research

Published on 12 Jul 2024

Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19

in Pharmacology of Infectious Diseases

Yasmin Silva-Santos
Roberta Liberato Pagni
Thais Helena Martins Gamon
Marcela Santiago Pacheco de Azevedo
Mônica Bielavsky
Maria Laura Goussain Darido
Danielle Bruna Leal de Oliveira
Edmarcia Elisa de Souza
Carsten Wrenger
Edson Luiz Durigon

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414406

913 views

Systematic Review

Published on 05 Jul 2024

Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B

in Pharmacology of Infectious Diseases

Na Wei
Bin Zheng
Hongfu Cai
Na Li
Jing Yang
Maobai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403805

625 views

Original Research

Published on 04 Jul 2024

Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders

in Pharmacology of Infectious Diseases

Ting-Hui Liu
Hsuan-Yi Liao
Chih-Cheng Chang
Chih-Cheng Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1384264

711 views

Systematic Review

Published on 03 Jul 2024

Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Mohammad Hosseini Hooshiar
Mohammad Sholeh
Masoumeh Beig
Khalil Azizian
Ebrahim Kouhsari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1284665

1,505 views
1 citation

Review

Published on 01 Jul 2024

Recent advances in the study of zika virus structure, drug targets, and inhibitors

in Pharmacology of Infectious Diseases

Yingqi Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418516

923 views

Review

Published on 21 Jun 2024

Polymyxins: recent advances and challenges

in Pharmacology of Infectious Diseases

Shan Yang
Hairui Wang
Dan Zhao
Shurong Zhang
Chenggong Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424765

1,461 views
1 citation

Editorial

Published on 19 Jun 2024

Editorial: Commercialization and industrialization of pharmacology of infectious diseases: 2022

in Pharmacology of Infectious Diseases

Yanqin Huang
Sue C. Nang
Yu-Wei Lin
Fekade Sime

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438072

451 views

Original Research

Published on 18 Jun 2024

Antimalarial and antioxidant activities of novel artesunate-ellagic acid hybrid compound in vitro and in vivo

in Pharmacology of Infectious Diseases

Ahmed A. Ishola
Joseph O. Adebayo
Isabela P. Ceravolo
Habibu Tijjani
Edson S. Bento
Henrique F. Goulart
Alessandre C. Crispim
Elizabeth A. Balogun
Antonio E. G. Santana
Antoniana U. Krettli

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1192659

1,068 views

Review

Published on 17 Jun 2024

Current research update on group B streptococcal infection related to obstetrics and gynecology

in Pharmacology of Infectious Diseases

Ying Liu
Hao Ai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1395673

889 views

Original Research

Published on 04 Jun 2024

Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients

in Pharmacology of Infectious Diseases

Lucie Polášková
Irena Murínová
Jana Gregorová
Ondřej Slanař
Martin Šíma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364681

704 views

Navigation group

Articles

Evaluating the protective effectiveness and risk factors of ursodeoxycholic acid on COVID-19 among outpatients

Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in Mycobacterium tuberculosis: A computational approach

Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury

Monoterpene antifungal activities: evaluating geraniol, citronellal, and linalool on Candida biofilm, host inflammatory responses, and structure–activity relationships

Development and validation of a prognostic nomogram to predict 30-day all-cause mortality in patients with CRO infection treated with colistin sulfate

Advancing vaccine development against Opisthorchis viverrini: A synergistic integration of omics technologies and advanced computational tools

Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19

Systematic review and meta-analysis: de novo combination of nucleos(t)ide analogs and pegylated interferon alpha versus pegylated interferon alpha monotherapy for the functional cure of chronic hepatitis B

Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders

Global trends of antimicrobial resistance rates in Neisseria gonorrhoeae: a systematic review and meta-analysis

Recent advances in the study of zika virus structure, drug targets, and inhibitors

Polymyxins: recent advances and challenges

Editorial: Commercialization and industrialization of pharmacology of infectious diseases: 2022

Antimalarial and antioxidant activities of novel artesunate-ellagic acid hybrid compound in vitro and in vivo

Current research update on group B streptococcal infection related to obstetrics and gynecology

Vancomycin population pharmacokinetics and dosing proposal for the initial treatment in obese adult patients